Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
ACI Worldwide
ACIW
$5.29B
| $3.57M | 0.01% |
+169,027
| New | +$3.81M |
|
1527
Vanguard S&P 500 ETF
VOO
$1.02T
| $3.57M | 0.01% |
20,316
+11,935
| +142% | +$2.22M |
|
1528
Fair Isaac
FICO
$24.6B
| $3.57M | 0.01% |
42,218
+34,655
| +458% | +$3.05M |
|
1529
Cumberland Pharmaceuticals
CPIX
$130M
| $3.56M | 0.01% |
617,065
+1,106
| +0.2% | +$6.89K |
|
1530
Home Depot
HD
$337B
| $3.56M | 0.01% |
30,799
-302,953
| -91% | -$35M |
|
1531
CALL
Edwards Lifesciences
EW
$52.4B
| $3.55M | 0.01% |
+150,000
| New | +$3.62M |
|
1532
Inogen
INGN
$147M
| $3.55M | 0.01% |
+73,074
| New | +$3.47M |
|
|
WDR
1533
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $3.55M | 0.01% |
102,028
+79,780
| +359% | +$3.3M |
|
|
VXX
1534
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $3.54M | 0.01% |
8,648
-44,475
| -84% | -$14.8M |
|
|
VIVO
1535
DELISTED
Meridian Bioscience Inc
VIVO
| $3.54M | 0.01% |
207,015
-153,553
| -43% | -$2.81M |
|
1536
Acacia Research
ACTG
$439M
| $3.52M | 0.01% |
387,896
-455,265
| -54% | -$4.1M |
|
1537
Graham Holdings Company
GHC
$4.99B
| $3.52M | 0.01% |
6,101
-9,295
| -60% | -$6.14M |
|
1538
Itron
ITRI
$4.32B
| $3.5M | 0.01% |
109,692
-38,697
| -26% | -$1.21M |
|
|
ZEN
1539
DELISTED
ZENDESK INC
ZEN
| $3.5M | 0.01% |
177,517
+58,123
| +49% | +$1.22M |
|
|
VRTV
1540
DELISTED
VERITIV CORPORATION
VRTV
| $3.49M | 0.01% |
93,705
-65,519
| -41% | -$2.4M |
|
|
YOKU
1541
DELISTED
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
| $3.49M | 0.01% |
197,740
-663,440
| -77% | -$12.3M |
|
|
TYPE
1542
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $3.48M | 0.01% |
159,398
+138,891
| +677% | +$3.19M |
|
1543
iShares Core S&P 500 ETF
IVV
$894B
| $3.48M | 0.01% |
18,040
+12,240
| +211% | +$2.5M |
|
1544
Ennis
EBF
$543M
| $3.47M | 0.01% |
200,095
+124,109
| +163% | +$2.09M |
|
1545
WaFd
WAFD
$2.68B
| $3.47M | 0.01% |
152,604
+136,528
| +849% | +$3.13M |
|
|
SBY
1546
DELISTED
Silver Bay Realty Trust Corp.
SBY
| $3.47M | 0.01% |
216,747
+142,250
| +191% | +$2.31M |
|
1547
Eldorado Gold
EGO
$12.6B
| $3.47M | 0.01% |
215,261
+65,572
| +44% | +$1.09M |
|
1548
InterContinental Hotels
IHG
$24.2B
| $3.46M | 0.01% |
75,812
+10,422
| +16% | +$533K |
|
1549
Nice
NICE
$5.88B
| $3.46M | 0.01% |
61,480
+20,024
| +48% | +$1.25M |
|
|
WNS
1550
DELISTED
WNS Holdings
WNS
| $3.45M | 0.01% |
123,481
+26,822
| +28% | +$786K |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.